Microsoft Defender vs Okta
Side-by-side comparison of AI visibility scores, market position, and capabilities
Microsoft's enterprise endpoint protection platform included in Microsoft 365 E5; benefiting from CrowdStrike's 2024 outage while AI-powered Copilot for Security integrates with Microsoft's $20B+ security business.
About
Microsoft Defender is Microsoft's comprehensive endpoint security platform — providing antivirus, anti-malware, endpoint detection and response (EDR), vulnerability management, and attack surface reduction across Windows, macOS, Linux, iOS, and Android devices. Part of Microsoft's Security portfolio (which generates $20+ billion annually), Microsoft Defender for Endpoint has become one of the most widely deployed enterprise security products as organizations already licensing Microsoft 365 E5 gain enterprise security capabilities that previously required separate vendor relationships with Symantec, CrowdStrike, or SentinelOne.
NASDAQ-listed (OKTA) independent identity platform with 19K+ customers at $2.26B revenue; Workforce Identity Cloud and Auth0 competing with Microsoft Entra for enterprise and developer IAM.
About
Okta is a San Francisco-based identity and access management (IAM) platform — the leading independent identity infrastructure provider — offering workforce identity (employee SSO, MFA, lifecycle management) and customer identity (Auth0 developer authentication platform) solutions for 19,000+ organizations. Listed on NASDAQ (NASDAQ: OKTA), Okta generated $2.26 billion in revenue in fiscal year 2025 (ending January 2025), growing through its Workforce Identity Cloud and Customer Identity Cloud (Auth0, acquired 2021 for $6.5 billion), serving enterprises from growth-stage startups to Fortune 500 companies securing access to cloud and on-premise applications.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Integrations
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.